FDA Advisory Committee Votes in Favor of EUA for Pfizer-BioNTech COVID-19 Vaccine in Children

The panel voted 17 to 0 to recommend that FDA grant Emergency Use Authorization for Pfizer-BioNTech’s COVID-19 vaccine in children aged 5 to 11 years old.